45 -1 (63) 2024 — Akhmedov F.K., Negmatshаeva M.S. — ANTIPHOSPHOLIPID SYNDROME: MORPHOLOGICAL CHARACTERISTICS OF THE PLACENTA AND PREMATURE BIRTH

ANTIPHOSPHOLIPID SYNDROME: MORPHOLOGICAL CHARACTERISTICS OF THE PLACENTA AND PREMATURE BIRTH

Akhmedov F.K., Bukhara State Medical Institute named after Abu Ali ibn Sina,  Andijan State Medical Institute

Negmatshаeva M.S., Bukhara State Medical Institute named after Abu Ali ibn Sina,  Andijan State Medical Institute

Negmatshаeva H.N., Bukhara State Medical Institute named after Abu Ali ibn Sina,  Andijan State Medical Institute

Akhmadzhonova G.M. Bukhara State Medical Institute named after Abu Ali ibn Sina,  Andijan State Medical Institute

Resume

The article is devoted to the data on the morphological characteristics of the placenta condition in women with identified antiphospholipid syndrome. The results of women with a complicated obstetric history and premature birth are given. Fragments of the placenta were studied to assess the morphological picture in AFS and preterm labor.

Keywords: spontaneous abortion, antiphospholipid syndrome, fetal loss, premature birth, obstetric complications.

First page

247

Last page

249

For citation: Akhmedov F.K., Negmatshаeva M.S., Negmatshаeva H.N., Akhmadzhonova G.M. – ANTIPHOSPHOLIPID SYNDROME: MORPHOLOGICAL CHARACTERISTICS OF THE PLACENTA AND PREMATURE BIRTH //New Day in Medicine 2024 1(63): 247 -249 https://newdaymedicine.com/index.php/2024/01/21/l-773/

LIST OF REFERENCES:

1. Ахмедов Ф.К., Курбонова З.Ш. Мочевая кислота – маркер развития преэклампсия // Новости дерматологии и репродуктивного здоровья. 2017; 3-4(II):27-29.
2. Ахмедов Ф.К., Курбанова З.Ш. Преэклампсияни ташхислашда қон ва сийдикда сийдик кислотаси концентрациясининг роли // Тиббиётда янги кун. 2017; 1:119-122.
3. Ахмедов Ф.Қ., Негматуллаева М.Н., Особенности состояния центральной гемодинамики и гемостаза у беременных с преэклампсии различной степени и тяжести // Новый день медицины. 2020; 1(29):147-150.
4. Ахмедов Ф.К., Негматуллаева М.Н., Состояние системы кровообращения и кардиогемодинамики у беременных женщин с легкой преэклампсией: проспективное открытое контролируемое исследование // Фарматека. 2020; 6(27):71-75.
5. Diamond JR, Wu B, Agarwal N, et al. Pharmacokinetic drug–drug interaction study of the angiopoietin-1/angiopoietin-2-inhibiting peptibody trebananib (AMG 386) and paclitaxel in patients with advanced solid tumors. // Invest New Drugs. 2015; 33:691-699.
6. Gulnoza Akhmadjonova, Gulnoza Turayeva. Evaluation of the microbial flora of the genital tract and the morphofunctional state of the endometrium in antiphospholipid syndrome // American Journal of Medicine and Medical Sciences 2022; 12(5):579-583 DOI: 10.5923/j.ajmms.20221205.26 579-583.
7. Gulnoza Akhmadjonova, Shukhrat Teshaev, Dilbar Nazhmutdinova, Khabiba Negmatshaeva. Clinical Characteristics of Women with Early Gestational Fetal Loss with Antiphospholipid Syndrome // American Journal of Medicine and Medical Sciences 2021; 11(8):563-568. DOI: 10.5923/j.ajmms.20211108.03.
8. Maniyozova GM, Turaeva G. Yu., Babich SM, Negmatshaeva HN, Mamajanova SA, Abdukaharova S. , Hakimova K. Use of Essentiale Forte N in Complex Treatment of Antiphospholipid Syndrome in Women of Ferghana Valley // Journal of Medical Research and Development . – Germany, Jan. 2015; 4(1):8-10.
9. Maniyozova G., Negmatshaeva H., Yuldasheva O., Turaeva G., Parpieva D. Use of enzymes in complex treatment of antiphospholipid syndrome in women with reproductive losses of andijan state // European medical Heals and Pharmaceutical Journal. – Chechiya, 2014; 7(I2):1-2.
10. Mori M, Bogdan A, Balassa T, Csabai T, Szekeres-Bartho J. The decidua-the maternal bed embracing the embryo-maintains the pregnancy. // Semin Immunopathol. 2016; 38:635-649.